Anton Willer

Anton Willer is a highly experienced professional in the field of molecular pharmacology and hematological malignancies. Currently serving as Senior Department Manager at Gubra since September 2024, Anton previously held roles such as Team Manager and Project Leader at Symphogen, Medical Advisor for Hematology at AstraZeneca, and Senior Scientist at Symphogen. Anton's research expertise includes clinical flow cytometry, monitoring minimal residual disease in leukemia patients, and the epigenetic factors involved in cancer. Educational qualifications include a PhD in Cellular and Molecular Biology from the University of Copenhagen, with an extensive academic and research background in transcriptional regulation and hematopoiesis.